NACB - Scientific Shorts
NACB - Scientific Shorts (formerly NACB Blog)
By Dr. Wendy Alderton, Chief Scientific Officer, Abcodia Ltd, UK
Over recent decades good progress has been made in survival for many types of cancer, including breast, colorectal, testicular, and prostate cancers. But some types of malignancies, including pancreatic cancer, have remained resistant to efforts to improve outcomes. Pancreatic cancer has a 5 year r...(Read More)
By Gregory Tsongalis, PhD
This week we have a blog post from Dr. Gregory Tsongalis, the 2013 winner of the AACC-NACB Award for outstanding contributions to clinical chemistry.  He discusses a new entity in laboratory medicine, miRNA.  While there are numerous potential applications in the literature, Dr. Tsongalis’ laborato...(Read More)